← All organizations
Highest phase reached
Phase 3
First clinical trial
Sep 1, 2012Last known activity
Jul 15, 2024
Timeline
2010s
- Mar 1, 2010
EuBiologics Co.,Ltd— Founded
Drugs by trial phase (18 distinct, 17 trials)
Phase 3 (8 own, 0 via acquisition)
Phase 1 (10 own, 0 via acquisition)
Indications
Studied for
Recent trials (19)
- NCT06409494Lead sponsorPhase 1Jul 15, 2024
- NCT06216093Lead sponsorPhase 1May 8, 2024
- NCT05739292Study directorPhase 1Feb 28, 2023
- NCT05739292Lead sponsorPhase 1Feb 28, 2023
- NCT05559983CollaboratorPhase 1Nov 30, 2022
- NCT05572879Lead sponsorPhase 3Oct 1, 2022
- NCT05603052Lead sponsorPhase 3Jul 11, 2022
- NCT04760236CollaboratorPhase 3May 20, 2021
- NCT04783311Lead sponsorPhase 1/Phase 2Feb 23, 2021
- NCT04830371Lead sponsorPhase 2/Phase 3Sep 7, 2020
- NCT04714229Lead sponsorPhase 1Sep 1, 2020
- NCT04714229Study directorPhase 1Sep 1, 2020
- NCT04830345Lead sponsorPhase 3Jun 29, 2020
- NCT04830358Lead sponsorPhase 1May 28, 2020
- NCT03970876Lead sponsorPhase 1/Phase 2Apr 19, 2019
Details
- Founded
- Seoul, KR Mar 1, 2010
- Last known activity
- Jul 15, 2024